National Reporting of Mortality Associated with Anaesthesia
In 1995, the Australian and New Zealand College of Anaesthetists (ANZCA) appointed a 'National' Anaesthetic Mortality Committee, consisting of the ANZCA President and Chairs of the State Mortality Committees. This Committee undertook to collate data from mortality committees in NSW, Victoria, South Australia, Western Australia, and Queensland to produce a triennial national report, of which the fourth, covering the years 2000-2002, has recently been published 3 . Due to inconsistency between states in relation to reporting requirements in the various Coronial Acts and (with the exception of Western Australia) dependence on voluntary reporting, a completely accurate figure for the rate of anaesthesia related mortality is not yet available. However it can be reasonably affirmed that there has been a substantial reduction in mortality to which anaesthesia 'probably' contributed, from 1 in 5000 in NSW reported by Holland in 1960 2 , to 1 in 10,000 in 1970, to 1 in 20,000 in 1990, and to the current national figure estimated at 1 in 56,000 in the most recent triennial report 3 . Differing methodology has made it difficult to compare the recent figure with reports from other countries, but it can be claimed that it is extremely low by international standards. In Australia, mortality 'directly' related to anaesthesia (as opposed to being only a contributory factor), is even lower, of the order of 1 in 180,000. It is expected that in the next triennium, with the full introduction of anaestheticspecific coding and a likely national review of Coronial Acts, more accurate data will be available.
Many factors have contributed to the high level of safety of anaesthesia in Australia. Improvements in training and education, the publication of guidelines for safe practice, including technical considerations and professional standards, and a very early commitment to the principles of quality assurance, have all played a role. There has also been a vast improvement in equipment and anaesthetic drugs, monitoring strategies and treatment regimens. There is indirect evidence that mortality reporting improves safety, and Australian and New Zealand anaesthetists must be commended for their long participation in hospital, state and national quality programs.
Where to in the Future?
It has been claimed that the anaesthesia mortality rate has reached an irreducible minimum and that continuing concentration on mortality review is unproductive. This argument is unsustainable, as no professional medical organization could support such a concept where death of a patient is not thoroughly reviewed, particularly with the current escalation in the use of new drugs and techniques. There is good evidence however, that there is substantial morbidity related to anaesthesia and pain management, providing a strong argument for detailed peer review of these adverse events in conjunction with notification of mortality.
The Victorian Consultative Council on Anaesthetic Mortality and Morbidity (VCCAMM), since its inception in 1976, has had the brief to study anaesthesiarelated morbidity and is convinced that with timely feedback there is the potential for considerable improvement in safety and the ability to provide more evidence for change than that provided by mortality studies alone. A very significant contribution to the recording of adverse events was the development of the national Anaesthesia Incident Monitoring Study (AIMS) in 1988, with a base in South Australia. Incidents that resulted in poor outcomes, or had the potential to do so, were reported anonymously to a central data repository. There followed numerous publications, which certainly accelerated the introduction of mandatory monitoring standards. Crisis management algorithms also were developed, which are widely used. Although there is a large amount of information in the data bank, recent feedback has not occurred. The Australian Society of Anaesthetists has given strong support to this program and it is hoped that further reports will soon be available.
Since the Quality in Australian Healthcare Study report, published in 1995 4 , there has been an explosion of quality assurance activities by many state and national health organizations. As a result there is a strong possibility that there may be fragmentation or duplication of input as well as lack of adequate clinical assessment. Assessment of adverse events must involve not only data acquisition, but also a qualitative element in providing information that can identify unsuspected problems in a timely manner. Thus, while having the potential to make useful contributions to other quality assurance programs, and recognizing the need to embrace the concept of systems analysis, the specialty must maintain independence in the conduct of its own long-standing programs.
ANZCA Council has accepted the recommendations of two task forces set up to review all aspects of its activities in quality and safety. To maintain leadership in this area it has established a special committee on quality and safety, to be chaired by Professor Alan Merry. It is anticipated that ANZCA, supported by the Australian and the New Zealand Societies of Anaesthetists, can provide leadership in establishing a framework for the improved coordination of quality assurance activities of anaesthetists in both countries.
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